Highline Capital Management as of June 30, 2019
Portfolio Holdings for Highline Capital Management
Highline Capital Management holds 31 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Catalent | 8.2 | $112M | 2.1M | 54.21 | |
Iqvia Holdings (IQV) | 6.6 | $90M | 561k | 160.90 | |
Sanderson Farms | 5.8 | $80M | 584k | 136.56 | |
Commercial Metals Company (CMC) | 5.8 | $79M | 4.4M | 17.85 | |
W.R. Grace & Co. | 5.4 | $74M | 974k | 76.11 | |
Eldorado Resorts | 5.2 | $71M | 1.5M | 46.07 | |
Anthem (ELV) | 5.1 | $69M | 246k | 282.21 | |
Royal Caribbean Cruises (RCL) | 4.9 | $68M | 557k | 121.21 | |
Take-Two Interactive Software (TTWO) | 4.7 | $64M | 567k | 113.53 | |
Arcelormittal Sa Luxembourg Ny Registry Sh (MT) | 4.1 | $56M | 3.1M | 18.03 | |
Tyson Foods Cl A (TSN) | 3.8 | $52M | 646k | 80.74 | |
BioMarin Pharmaceutical (BMRN) | 3.8 | $52M | 607k | 85.65 | |
Marvell Technology Group Ord | 3.6 | $50M | 2.1M | 23.87 | |
Apple Put Option (AAPL) | 3.6 | $49M | 246k | 197.92 | |
Boyd Gaming Corporation (BYD) | 3.5 | $48M | 1.8M | 26.94 | |
Vici Pptys (VICI) | 3.4 | $46M | 2.1M | 22.04 | |
SYSCO Corporation (SYY) | 3.2 | $44M | 619k | 70.72 | |
Meritor | 2.9 | $40M | 1.6M | 24.25 | |
Urogen Pharma (URGN) | 2.7 | $36M | 1.0M | 35.94 | |
Pegasystems (PEGA) | 2.6 | $36M | 503k | 71.21 | |
Align Technology (ALGN) | 2.0 | $28M | 101k | 273.70 | |
Ultragenyx Pharmaceutical (RARE) | 1.8 | $25M | 391k | 63.50 | |
Glu Mobile | 1.6 | $22M | 3.1M | 7.18 | |
Far Pt Acquisition Corp Unit 06/01/2025 | 1.6 | $22M | 2.1M | 10.67 | |
Amicus Therapeutics (FOLD) | 1.4 | $19M | 1.5M | 12.48 | |
Alector (ALEC) | 0.9 | $12M | 646k | 19.00 | |
Voyager Therapeutics (VYGR) | 0.6 | $8.1M | 297k | 27.22 | |
Adaptive Biotechnologies Cor (ADPT) | 0.4 | $5.8M | 121k | 48.30 | |
Pinduoduo Sponsored Ads Put Option (PDD) | 0.3 | $3.6M | 175k | 20.63 | |
Health Sciences Acqustn Corp Unit 04/01/2024 | 0.2 | $3.2M | 300k | 10.60 | |
Arcturus Therapeutics Hldg I (ARCT) | 0.2 | $2.1M | 218k | 9.44 |